新加坡

????新加坡的目標是成為世界醫(yī)療技術(shù)中心，這個城邦國家為此制定了一攬子激勵計劃，以吸引大型公司和商界新貴來此落戶。該國推出的項目包括稅收抵免研發(fā)開支，并且可以使用新加坡先進的電信基礎設施，以及從新加坡一流工程學院畢業(yè)的科技人才。如今，這些激勵措施似乎正在發(fā)揮作用：近幾年，醫(yī)藥行業(yè)巨頭葛蘭素史克公司（GlaxoSmithKline）、諾華制藥（Novartis）、雅培制藥（Abbott）和羅氏公司（Roche）均開始在新加坡大規(guī)模開展業(yè)務。

優(yōu)勢

?????科技

?????教育

?????對公司有利的政策

Singapore

????Singapore has its sights set on becoming a hub for health technology, and the city-state has developed a package of incentives to lure large employers and upstarts alike. The program includes tax credits for R&D spending, plus access to Singapore's cutting-edge telecom infrastructure and scientific talent graduating from the country's highly ranked engineering programs. The inducements seem to be working: In recent years pharmaceutical giants GlaxoSmithKline, Novartis, Abbott, and Roche have opened major operations in Singapore.

Good for

?????Science

?????Education

?????Business-friendly policies